Annual Total Expenses
$11.87 M
-$7.07 M-37.34%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings annual total expenses is currently $11.87 million, with the most recent change of -$7.07 million (-37.34%) on 30 September 2024. During the last 3 years, it has fallen by -$13.70 million (-53.59%). SONN annual total expenses is now -60.47% below its all-time high of $30.02 million, reached on 30 September 2022.SONN Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$3.17 M
-$355.30 K-10.07%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings quarterly total expenses is currently $3.17 million, with the most recent change of -$355.30 thousand (-10.07%) on 30 September 2024. Over the past year, it has increased by +$1.88 million (+144.58%). SONN quarterly total expenses is now -61.79% below its all-time high of $8.31 million, reached on 31 March 2022.SONN Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | +144.6% |
| 3 y3 years | -53.6% | -50.0% |
| 5 y5 years | +152.1% | - |
SONN Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.5% | at low | -61.8% | +144.6% |
| 5 y | 5 years | -60.5% | +152.1% | -61.8% | +144.6% |
| alltime | all time | -60.5% | +152.1% | -61.8% | +144.6% |
Sonnet BioTherapeutics Holdings Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | $11.87 M(-37.3%) | $3.17 M(-10.1%) |
| June 2024 | - | $3.53 M(-8.8%) |
| Mar 2024 | - | $3.87 M(+198.2%) |
| Dec 2023 | - | $1.30 M(-64.3%) |
| Sept 2023 | $18.94 M(-36.9%) | $3.64 M(-8.0%) |
| June 2023 | - | $3.95 M(-30.7%) |
| Mar 2023 | - | $5.70 M(+0.9%) |
| Dec 2022 | - | $5.65 M(-24.1%) |
| Sept 2022 | $30.02 M | $7.44 M(-6.2%) |
| June 2022 | - | $7.93 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.31 M(+30.9%) |
| Dec 2021 | - | $6.34 M(-14.6%) |
| Sept 2021 | $25.57 M(+46.9%) | $7.43 M(+19.1%) |
| June 2021 | - | $6.24 M(+3.4%) |
| Mar 2021 | - | $6.04 M(+3.0%) |
| Dec 2020 | - | $5.86 M(-21.7%) |
| Sept 2020 | $17.41 M(+269.8%) | $7.49 M(+51.6%) |
| June 2020 | - | $4.94 M(-29.8%) |
| Mar 2020 | - | $7.04 M |
| Sept 2019 | $4.71 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual total expenses?
- What is the all time high annual total expenses for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual total expenses year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly total expenses year-on-year change?
What is Sonnet BioTherapeutics Holdings annual total expenses?
The current annual total expenses of SONN is $11.87 M
What is the all time high annual total expenses for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual total expenses is $30.02 M
What is Sonnet BioTherapeutics Holdings annual total expenses year-on-year change?
Over the past year, SONN annual total expenses has changed by -$7.07 M (-37.34%)
What is Sonnet BioTherapeutics Holdings quarterly total expenses?
The current quarterly total expenses of SONN is $3.17 M
What is the all time high quarterly total expenses for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly total expenses is $8.31 M
What is Sonnet BioTherapeutics Holdings quarterly total expenses year-on-year change?
Over the past year, SONN quarterly total expenses has changed by +$1.88 M (+144.58%)